Td Asset Management Inc Avidity Biosciences, Inc. Transaction History

Td Asset Management Inc

$106 Billion
Q4 2024

A detailed history of Td Asset Management Inc transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 415,172 shares of RNA stock, worth $12.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

415,172

Previous 434,972 4.55%

Holding current value

$12.7 Million

Previous $20 Million 39.57%

% of portfolio

0.01%

Previous 0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$29.08 - $52.5 $575,784 - $1.04 Million	-19,800 Reduced 4.55%	415,172 $12.1 Million
Q3 2024 Nov 01, 2024	SELL	$37.21 - $48.14 $2.92 Million - $3.77 Million	-78,366 Reduced 15.27%	434,972 $20 Million
Q2 2024 Aug 02, 2024	BUY	$22.73 - $40.85 $6.82 Million - $12.3 Million	300,054 Added 140.68%	513,338 $21 Million
Q1 2024 May 08, 2024	SELL	$9.16 - $25.52 $498,743 - $1.39 Million	-54,448 Reduced 20.34%	213,284 $5.44 Million
Q3 2023 Oct 27, 2023	BUY	$6.3 - $11.35 $843,355 - $1.52 Million	133,866 Added 100.0%	267,732 $1.71 Million
Q2 2023 Aug 09, 2023	SELL	$10.62 - $17.34 $198,615 - $324,292	-18,702 Reduced 12.26%	133,866 $1.48 Million
Q1 2023 May 10, 2023	SELL	$15.35 - $25.65 $181,851 - $303,875	-11,847 Reduced 7.21%	152,568 $2.34 Million
Q4 2022 Feb 06, 2023	BUY	$10.06 - $22.66 $313,308 - $705,723	31,144 Added 23.37%	164,415 $3.65 Million
Q3 2022 Nov 07, 2022	BUY	$15.46 - $23.43 $12,368 - $18,744	800 Added 0.6%	133,271 $2.23 Million
Q2 2022 Aug 04, 2022	SELL	$11.18 - $20.5 $118,675 - $217,607	-10,615 Reduced 7.42%	132,471 $1.93 Million
Q1 2022 May 10, 2022	SELL	$14.2 - $23.78 $74,663 - $125,035	-5,258 Reduced 3.54%	143,086 $2.64 Million
Q4 2021 Feb 10, 2022	BUY	$20.4 - $28.66 $913,287 - $1.28 Million	44,769 Added 43.22%	148,344 $3.53 Million
Q3 2021 Nov 09, 2021	BUY	$18.16 - $25.21 $1.37 Million - $1.91 Million	75,627 Added 270.6%	103,575 $2.55 Million
Q1 2021 May 14, 2021	BUY	$20.28 - $28.15 $96,106 - $133,402	4,739 Added 20.42%	27,948 $610,000
Q4 2020 Feb 16, 2021	BUY	$24.73 - $35.12 $39,568 - $56,191	1,600 Added 7.4%	23,209 $592,000
Q3 2020 Nov 10, 2020	BUY	$23.35 - $35.94 $30,355 - $46,722	1,300 Added 6.4%	21,609 $608,000
Q2 2020 Aug 13, 2020	BUY	$26.62 - $31.5 $540,625 - $639,733	20,309 New	20,309 $574,000

Others Institutions Holding RNA

# of Institutions

258

Shares Held

108M

Call Options Held

517K

Put Options Held

717K

View Full List

About Avidity Biosciences, Inc.

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $1.6B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

More about RNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Account

Td Asset Management Inc Avidity Biosciences, Inc. Transaction History